Search Results 291-300 of 14685 for Hyperuricaemia / gout risk

  1. Bemarituzumab Plus Chemotherapy And Nivolumab Versus Chemotherapy And Nivolumab Alone - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Clinical Studies of Epidemiology, Risk Factors and Prognosis in Hepatobiliary Cancer

    The Hepatobiliary Cancer Lab of Lewis R. Roberts, M.B., Ch.B., Ph.D., conducts numerous clinical studies of hepatobiliary cancer, including its epidemiology ...

  3. Medical Research & Education - Mayo Clinic News Network

    July 29, 2026. Experimental immunotherapy may help patients with high-risk bladder cancer avoid bladder removal surgery featured. Cancer. Experimental ...

  4. About 'Our take' - Mayo Clinic

    Talk to your doctor or other healthcare professional about the risks and benefits before adding one of these products to your routine. Follow up with your ...

  5. Urinary tract infection (UTI)

    Most infections involve the lower urinary tract — the bladder and the urethra. Women have a higher risk of getting UTIs than men. A urinary tract infection that ...

  6. https://www.mayoclinic.org/arabic_patient_consumer_video.xml

  7. Young Fibromyalgia Patients Report Worse Symptoms Than Older Patients, Mayo Clinic Study Shows

    Hospitalization is a significant risk factor for gout flares in people already diagnosed with gout. To interview Dr. Oh or other Mayo Clinic researchers ...

  8. https://www.mayoclinic.org/patient_consumer_web.xml

  9. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers capture first signs of ovarian cancer risk featured image. Research. Mayo Clinic researchers capture first signs of ovarian cancer risk.

  10. A Randomized Phase 2 Study Of Combination Atezolizumab And CDX-1127 (Varlilumab) With Or Without Addition Of Cobimetinib In Previously Treated Unresectable Biliary Tract Cancers - Mayo Clinic

    About this study. The purpose of this study is to assess the response rate (ORR) of patients with unresectable, pre-treated biliary cancers treated with the ...